The Valley Desk

NCT07789483 · Interventional trial

An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy

Overall registry status Not yet recruiting

Phase 3

Conditions Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov